Cardiopulmonary Imaging in Sarcoidosis

Clinics in Chest Medicine

Volumn 29, Issue 3, 2008, Pages 429-443

  Akbar, Jason J ^a   Meyer, Cris A ^a   Shipley, Ralph T ^a   Vagal, Achala S ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA METHYLTYROSINE F 18; AMMONIA NITROGEN 13; CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; INFLIXIMAB; METHOXYISOBUTLYISONITRILE TC 99M; RADIOPHARMACEUTICAL AGENT;

CARDIOPULMONARY HEMODYNAMICS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; GRANULOMATOSIS; HUMAN; IMAGE ENHANCEMENT; IMAGING SYSTEM; LUNG FUNCTION TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SARCOIDOSIS; THORAX RADIOGRAPHY;

DIAGNOSIS, DIFFERENTIAL; HEART; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY, THORACIC; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 44649093951     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.03.015     Document Type: Review

References (72)

1. Martin L. Breathe easy: a guide to lung and respiratory diseases for patients and their families (1984), Prentice-Hall, Englewood Cliffs (NJ). http://www.lakesidepress.com/pulmonary/books/breathe/Secto.htm Accessed November 19, 2007
2. Shimada T., Shimada K., Sakane T., et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 110 7 (2001) 520-527
3. Nunes H., Brillet P., Valeyre D., et al. Imaging in sarcoidosis. Semin Respir Crit Care Med 28 1 (2007) 102-120
4. Hansell D., Armstrong P., and Lynch D. Imaging of diseases of the chest. 4th edition (2005), Elsevier Mosby, Philadelphia p. 631-52
5. Vagal A., Shipley R., and Meyer C. Radiological manifestations of sarcoidosis. Clin Dermatol 25 3 (2007) 312-325
6. Rockoff S., and Rohatgi P. Unusual manifestations of thoracic sarcoidosis. AJR Am J Roentgenol 144 (1985) 513-526
7. Conant E., Glickstein M., Mahar P., et al. Pulmonary sarcoidosis in the older patient: conventional radiographic features. Radiology 169 (1988) 315-319
8. Lynch J. Computed tomographic scanning in sarcoidosis. Semin Respir Crit Care Med 24 4 (2003) 393-418
9. Muller N., Mawson J., Mathieson J., et al. Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings. Radiology 171 (1989) 613-618
10. Fraser R., Muller N., Colman N., et al. Diagnosis of diseases of the chest. 4th edition (1999), W.B. Saunders, Philadelphia p. 1533-83
11. Soskel N., and Sharma O. Pleural involvement in sarcoidosis: case presentation and detailed review of the literature. Semin Respir Med 13 (1992) 492-514
12. Sharma O., and Gordonson J. Pleural effusion in sarcoidosis: a report of six cases. Thorax 30 (1975) 95-101
13. Littner M., Schachter E., Putman C., et al. The clinical assessment of roentgenographically atypical pulmonary sarcoidosis. Am J Med 62 (1977) 361-368
14. Wollschlager C., and Khan F. Aspergillomas complicating sarcoidosis: a prospective study in 100 patients. Chest 86 (1984) 585-588
15. Libshitz H., Atkinson G., and Israel H. Pleural thickening as a manifestation of aspergillus superinfection. Am J Roentgenol Radium Ther Nucl Med 120 (1974) 883-886
16. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160 2 (1999) 736-755
17. Baughman R., Drent M., Kavuru M., et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174 7 (2006) 795-802 [Epub 2006 Jul 13]
18. Atzeni F., Doria A., Carrabba M., et al. Potential target of infliximab in autoimmune and inflammatory diseases. Autoimmun Rev 6 8 (2007) 529-536 [Epub 2007 Apr 16]
19. Uthman I., Touma Z., and Khoury M. Cardiac sarcoidosis responding to monotherapy with infliximab. Clin Rheumatol 26 11 (2007) 2001-2003 [Epub 2007 Mar 30]
20. Doty J., Mazur J., and Judson M. Treatment of sarcoidosis with infliximab. Chest 127 3 (2005) 1064-1071
21. Mayo J., Aldrich J., and Muller N. Fleischner Society. Radiation exposure at chest CT: a statement of the Fleischner Society. Radiology 228 1 (2003) 15-21
22. Sider L., and Horton E. Hilar and mediastinal adenopathy in sarcoidosis as detected by computed tomography. J Thorac Imaging 5 2 (1990) 77-80
23. Lynch D., Webb W., Gamsu G., et al. Computed tomography in pulmonary sarcoidosis. J Comput Assist Tomogr 13 (1989) 405-410
24. Muller N., Kullnig P., and Miller R. The CT findings of pulmonary sarcoidosis: analysis of 25 patients. AJR Am J Roentgenol 152 (1989) 1179-1182
25. Webb R., Muller N., and Naidich D. High-resolution CT of the lung. 3rd edition (2001), Lippincott, Williams & Wilkins, Philadelphia p. 286-301, 547-53
26. Battesti J., Saumon G., Valeyre D., et al. Pulmonary sarcoidosis with an alveolar radiographic pattern. Thorax 37 (1982) 448-452
27. Nishimura K., Itoh H., Kitaichi M., et al. Pulmonary sarcoidosis: correlation of CT and histopathologic findings. Radiology 189 (1993) 105-109
28. Nakatsu M., Hatabu H., Morikawa K., et al. Large coalescent parenchymal nodules in pulmonary sarcoidosis: "sarcoid galaxy"sign. AJR Am J Roentgenol 178 6 (2002) 1389-1393
29. Heo J., Choi Y., Jeon S., et al. Pulmonary tuberculosis: another disease showing clusters of small nodules. AJR Am J Roentgenol 184 2 (2005) 639-642
30. Honda O., Johnkoh T., Ichikado K., et al. Comparison of high resolution CT findings of sarcoidosis, lymphoma and lymphangitic carcinoma: is there any difference of involved interstitium?. J Comput Assist Tomogr 23 (1999) 374-379
31. Lenique F., Brauner M., and Grenier P. CT assessment of bronchi in sarcoidosis: endoscopic and pathologic correlations. Radiology 194 2 (1995) 419-423
32. Hansell D., Milne D., Wilsher M., et al. Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin section CT. Radiology 209 (1998) 697-704
33. Muller N., Mawson J., Mathieson J., et al. Correlation of CT with clinical, functional, and radiological findings. Radiology 171 (1989)
34. Drent M., De Vries J., Lenters M., et al. Sarcoidosis: assessment of disease severity using HRCT. Eur Radiol 13 11 (2003) 2462-2471 [Epub 2003 Jun 17]
35. Smedema J., Snoep G., van Kroonenburgh M., et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the netherlands. Chest 128 1 (2005) 30-35
36. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 184 1 (2005) 249-254
37. Sato Y., Matsumoto N., Kunimasa T., et al. Multiple involvements of cardiac sarcoidosis in both left and right ventricles and papillary muscles detected by delayed-enhanced magnetic resonance imaging. Int J Cardiol (2007 Aug 7) [Epub ahead of print]
38. Osman F., Foundon A., Leyva P., et al. Early diagnosis of cardiac sarcoidosis using magnetic resonance imaging. Int J Cardiol 125 1 (2008) e4-e5
39. Redheuil A.B., Paziaud O., and Mousseaux E. Ventricular tachycardia and cardiac sarcoidosis: correspondence between MRI and electrophysiology. Eur Heart J 27 12 (2006) 1430 [Epub 2005 Oct 24]
40. Sanz J., Goyenechea M., and Poon M. Cardiac sarcoidosis detected with magnetic resonance imaging. Eur Heart J 27 14 (2006) 1639 [Epub 2006 Jan 25]
41. Chandra M., Silverman M., Oshinski J., et al. Diagnosis of cardiac sarcoidosis aided by MRI. Chest 110 2 (1996) 562-565
42. Nemeth M., Muthupillai R., Wilson J., et al. Cardiac sarcoidosis detected by delayed-hyperenhancement magnetic resonance imaging. Tex Heart Inst J 31 1 (2004) 99-102
43. Serra J., Monte G., Mello E., et al. Images in cardiovascular medicine: cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging. Circulation 107 20 (2003) 188-189
44. Doughan A., and Williams B. Cardiac sarcoidosis. Heart 92 2 (2006) 282-288
45. Vignaux O., Dhote R., Duboc D., et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr 26 5 (2002) 762-767
46. Smedema J., Snoep G., van Kroonenburgh M., et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45 10 (2005) 1683-1690
47. Slater G., Rodriguez E., Lima J., et al. A unique presentation of cardiac sarcoidosis. AJR Am J Roentgenol 180 6 (2003) 1738-1739
48. Schulz-Menger J., Strohm O., Dietz R., et al. Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging. MAGMA 11 1-2 (2000) 82-83
49. Doherty M., Kumar S., Nicholson A., et al. Cardiac sarcoidosis: the value of magnetic resonance imaging in diagnosis and assessment of response to treatment. Respir Med 92 4 (1998) 697-699
50. Stauder N., Bader B., Fenchel M., et al. Images in cardiovascular medicine: follow-up of cardiac sarcoidosis by magnetic resonance imaging. Circulation 111 11 (2005) e158-e160
51. Vignaux O., Dhote R., Duboc D., et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 122 6 (2002) 1895-1901
52. Borchert B., Lawrenz T., Bartelsmeier M., et al. Utility of endomyocardial biopsy guided by delayed enhancement areas on magnetic resonance imaging in the diagnosis of cardiac sarcoidosis. Clin Res Cardiol 96 10 (2007) 759-762 [Epub 2007 Aug 21]
53. Shorr A., Helman D., Davies D., et al. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 25 5 (2005) 783-788
54. Baughman R., Engel P., Meyer C., et al. Pulmonary hypertension in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 23 2 (2006) 108-116
55. Roeleveld R., Marcus J., Faes T., et al. Interventricular septal configuration at MR imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 234 3 (2005) 710-717 [Epub 2005 Jan 5]
56. Dellegrottaglie S., Sanz J., Poon M., et al. Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology 243 1 (2007) 63-69
57. Kanao S., Tadamura E., Yamamuro M., et al. Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging. J Comput Assist Tomogr 29 6 (2005) 745-748
58. Taaleb K., Kaiser K., and Wieler H. Elevated uptake of F-18 FDG in PET scans in nonmalignant disease. Clin Nucl Med 25 11 (2000) 939-940
59. Lewis P., and Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 35 10 (1994) 1647-1649
60. Kaira K., Oriuchi N., Otani Y., et al. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest 131 4 (2007) 1019-1027
61. Cohen P., and Kurzrock R. Sarcoidosis and malignancy. Clin Dermatol 25 3 (2007) 326-333
62. Yamagishi H., Shirai N., Takagi M., et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med 44 7 (2003) 1030-1036
63. Yamada Y., Uchida Y., Tatsumi K., et al. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. J Nucl Med 39 7 (1998) 1160-1166
64. Khorsand A., Graf S., Eidherr H., et al. Gated cardiac 13N-NH3 PET for assessment of left ventricular volumes, mass, and ejection fraction: comparison with electrocardiography-gated 18F-FDG PET. J Nucl Med 46 12 (2005) 2009-2013
65. Kaira K., Ishizuka T., Yanagitani N., et al. Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis. Clin Nucl Med 32 2 (2007) 114-116
66. Gyorik S., Ceriani L., Menafoglio A., et al. 18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker. Thorax 62 6 (2007) 560
67. Milman N., Mortensen J., and Sloth C. Fluorodeoxyglucose PET scan in pulmonary sarcoidosis during treatment with inhaled and oral corticosteroids. Respiration 70 4 (2003) 408-413
68. Ishimaru S., Tsujino I., Takei T., et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 26 15 (2005) 1538-1543 [Epub 2005 Apr 4]
69. Okumura W., Iwasaki T., Toyama T., et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 45 12 (2004) 1989-1998
70. Nishiyama Y., Yamamoto Y., Fukunaga K., et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 47 10 (2006) 1571-1576
71. Xiu Y., Yu J., Cheng E., et al. Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy. Clin Nucl Med 30 3 (2005) 193-195
72. Luh S., Wu T., Wang Y., et al. Experiences and benefits of positron emitted tomography-computed tomography (PET-CT) combined with video-assisted thoracoscopic surgery (VATS) in the diagnosis of Stage 1 sarcoidosis. J Zhejiang Univ Sci B 8 6 (2007) 410-415